rs5183

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000685.5(AGTR1):​c.1062A>G​(p.Pro354Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0673 in 1,613,898 control chromosomes in the GnomAD database, including 6,107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1976 hom., cov: 32)
Exomes 𝑓: 0.062 ( 4131 hom. )

Consequence

AGTR1
NM_000685.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.24

Publications

24 publications found
Variant links:
Genes affected
AGTR1 (HGNC:336): (angiotensin II receptor type 1) Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed; however, it is now believed that there is only one type 1 receptor gene in humans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2020]
AGTR1 Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • essential hypertension, genetic
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 3-148742097-A-G is Benign according to our data. Variant chr3-148742097-A-G is described in ClinVar as Benign. ClinVar VariationId is 256758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGTR1NM_000685.5 linkc.1062A>G p.Pro354Pro synonymous_variant Exon 3 of 3 ENST00000349243.8 NP_000676.1 P30556Q53YY0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGTR1ENST00000349243.8 linkc.1062A>G p.Pro354Pro synonymous_variant Exon 3 of 3 1 NM_000685.5 ENSP00000273430.3 P30556

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18214
AN:
151938
Hom.:
1965
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.293
Gnomad AMI
AF:
0.0670
Gnomad AMR
AF:
0.0552
Gnomad ASJ
AF:
0.0302
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0449
Gnomad FIN
AF:
0.0784
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0566
Gnomad OTH
AF:
0.0883
GnomAD2 exomes
AF:
0.0615
AC:
15377
AN:
249974
AF XY:
0.0586
show subpopulations
Gnomad AFR exome
AF:
0.301
Gnomad AMR exome
AF:
0.0341
Gnomad ASJ exome
AF:
0.0258
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0694
Gnomad NFE exome
AF:
0.0540
Gnomad OTH exome
AF:
0.0510
GnomAD4 exome
AF:
0.0618
AC:
90319
AN:
1461842
Hom.:
4131
Cov.:
35
AF XY:
0.0605
AC XY:
43998
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.301
AC:
10072
AN:
33478
American (AMR)
AF:
0.0360
AC:
1610
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0275
AC:
718
AN:
26132
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39696
South Asian (SAS)
AF:
0.0462
AC:
3985
AN:
86258
European-Finnish (FIN)
AF:
0.0700
AC:
3740
AN:
53410
Middle Eastern (MID)
AF:
0.0562
AC:
324
AN:
5768
European-Non Finnish (NFE)
AF:
0.0592
AC:
65784
AN:
1111984
Other (OTH)
AF:
0.0675
AC:
4079
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
5048
10096
15144
20192
25240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2594
5188
7782
10376
12970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18258
AN:
152056
Hom.:
1976
Cov.:
32
AF XY:
0.118
AC XY:
8747
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.293
AC:
12155
AN:
41420
American (AMR)
AF:
0.0550
AC:
841
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0302
AC:
105
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.0439
AC:
211
AN:
4808
European-Finnish (FIN)
AF:
0.0784
AC:
831
AN:
10594
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0566
AC:
3851
AN:
67994
Other (OTH)
AF:
0.0874
AC:
185
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
719
1438
2157
2876
3595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0716
Hom.:
2092
Bravo
AF:
0.128
Asia WGS
AF:
0.0310
AC:
106
AN:
3478
EpiCase
AF:
0.0569
EpiControl
AF:
0.0573

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular dysgenesis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.011
DANN
Benign
0.30
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5183; hg19: chr3-148459884; COSMIC: COSV62560389; API